FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3125966940> ?p ?o ?g. }

• W3125966940 endingPage "e001931" @default.
• W3125966940 startingPage "e001931" @default.
• W3125966940 abstract "Background Patients with cancer who are infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are more likely to develop severe illness and die compared with those without cancer. The impact of immune checkpoint inhibition (ICI) on the severity of COVID-19 illness is unknown. The aim of this study was to investigate whether ICI confers an additional risk for severe COVID-19 in patients with cancer. Methods We analyzed data from 110 patients with laboratory-confirmed SARS-CoV-2 while on treatment with ICI without chemotherapy in 19 hospitals in North America, Europe and Australia. The primary objective was to describe the clinical course and to identify factors associated with hospital and intensive care (ICU) admission and mortality. Findings Thirty-five (32%) patients were admitted to hospital and 18 (16%) died. All patients who died had advanced cancer, and only four were admitted to ICU. COVID-19 was the primary cause of death in 8 (7%) patients. Factors independently associated with an increased risk for hospital admission were ECOG ≥2 (OR 39.25, 95% CI 4.17 to 369.2, p=0.0013), treatment with combination ICI (OR 5.68, 95% CI 1.58 to 20.36, p=0.0273) and presence of COVID-19 symptoms (OR 5.30, 95% CI 1.57 to 17.89, p=0.0073). Seventy-six (73%) patients interrupted ICI due to SARS-CoV-2 infection, 43 (57%) of whom had resumed at data cut-off. Interpretation COVID-19–related mortality in the ICI-treated population does not appear to be higher than previously published mortality rates for patients with cancer. Inpatient mortality of patients with cancer treated with ICI was high in comparison with previously reported rates for hospitalized patients with cancer and was due to COVID-19 in almost half of the cases. We identified factors associated with adverse outcomes in ICI-treated patients with COVID-19." @default.
• W3125966940 created "2021-02-01" @default.
• W3125966940 creator A5000104802 @default.
• W3125966940 creator A5005778227 @default.
• W3125966940 creator A5006078149 @default.
• W3125966940 creator A5007787317 @default.
• W3125966940 creator A5008158683 @default.
• W3125966940 creator A5008479799 @default.
• W3125966940 creator A5009023899 @default.
• W3125966940 creator A5009718678 @default.
• W3125966940 creator A5010492722 @default.
• W3125966940 creator A5017136846 @default.
• W3125966940 creator A5022157436 @default.
• W3125966940 creator A5022162371 @default.
• W3125966940 creator A5022503555 @default.
• W3125966940 creator A5022520811 @default.
• W3125966940 creator A5029398339 @default.
• W3125966940 creator A5033270846 @default.
• W3125966940 creator A5034365278 @default.
• W3125966940 creator A5035343389 @default.
• W3125966940 creator A5039860031 @default.
• W3125966940 creator A5040969461 @default.
• W3125966940 creator A5044736874 @default.
• W3125966940 creator A5044960572 @default.
• W3125966940 creator A5045766235 @default.
• W3125966940 creator A5047088155 @default.
• W3125966940 creator A5047644166 @default.
• W3125966940 creator A5048013287 @default.
• W3125966940 creator A5051762484 @default.
• W3125966940 creator A5056132643 @default.
• W3125966940 creator A5056685282 @default.
• W3125966940 creator A5058076973 @default.
• W3125966940 creator A5059961435 @default.
• W3125966940 creator A5064097238 @default.
• W3125966940 creator A5064923908 @default.
• W3125966940 creator A5069095893 @default.
• W3125966940 creator A5070244587 @default.
• W3125966940 creator A5070590609 @default.
• W3125966940 creator A5071577704 @default.
• W3125966940 creator A5071929183 @default.
• W3125966940 creator A5072533566 @default.
• W3125966940 creator A5080271286 @default.
• W3125966940 creator A5080783554 @default.
• W3125966940 creator A5082278497 @default.
• W3125966940 creator A5083061830 @default.
• W3125966940 creator A5083581386 @default.
• W3125966940 creator A5084967339 @default.
• W3125966940 creator A5086473468 @default.
• W3125966940 creator A5087767413 @default.
• W3125966940 creator A5088390068 @default.
• W3125966940 creator A5089297467 @default.
• W3125966940 date "2021-01-01" @default.
• W3125966940 modified "2023-10-18" @default.
• W3125966940 title "Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition" @default.
• W3125966940 cites W2097855813 @default.
• W3125966940 cites W2773643507 @default.
• W3125966940 cites W2887577080 @default.
• W3125966940 cites W2903771841 @default.
• W3125966940 cites W3006645647 @default.
• W3125966940 cites W3008028633 @default.
• W3125966940 cites W3008090866 @default.
• W3125966940 cites W3008827533 @default.
• W3125966940 cites W3009486036 @default.
• W3125966940 cites W3011508332 @default.
• W3125966940 cites W3012421327 @default.
• W3125966940 cites W3014831688 @default.
• W3125966940 cites W3015599879 @default.
• W3125966940 cites W3017452948 @default.
• W3125966940 cites W3019342843 @default.
• W3125966940 cites W3021577619 @default.
• W3125966940 cites W3023189656 @default.
• W3125966940 cites W3024048796 @default.
• W3125966940 cites W3028965239 @default.
• W3125966940 cites W3030573714 @default.
• W3125966940 cites W3031797097 @default.
• W3125966940 cites W3034965161 @default.
• W3125966940 cites W3037848912 @default.
• W3125966940 cites W3042580192 @default.
• W3125966940 cites W3080162924 @default.
• W3125966940 cites W3165838540 @default.
• W3125966940 cites W4210642183 @default.
• W3125966940 doi "https://doi.org/10.1136/jitc-2020-001931" @default.
• W3125966940 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7817383" @default.
• W3125966940 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33468556" @default.
• W3125966940 hasPublicationYear "2021" @default.
• W3125966940 type Work @default.
• W3125966940 sameAs 3125966940 @default.
• W3125966940 citedByCount "42" @default.
• W3125966940 countsByYear W31259669402021 @default.
• W3125966940 countsByYear W31259669402022 @default.
• W3125966940 countsByYear W31259669402023 @default.
• W3125966940 crossrefType "journal-article" @default.
• W3125966940 hasAuthorship W3125966940A5000104802 @default.
• W3125966940 hasAuthorship W3125966940A5005778227 @default.
• W3125966940 hasAuthorship W3125966940A5006078149 @default.
• W3125966940 hasAuthorship W3125966940A5007787317 @default.
• W3125966940 hasAuthorship W3125966940A5008158683 @default.
• W3125966940 hasAuthorship W3125966940A5008479799 @default.

• next